Characteristics and In-Hospital Outcomes of Peripartum Cardiomyopathy Diagnosed During Delivery in the United States From the Nationwide Inpatient Sample (NIS) Database.

[1]  N. Bello,et al.  Molecular mechanisms of peripartum cardiomyopathy: A vascular/hormonal hypothesis. , 2015, Trends in cardiovascular medicine.

[2]  Anas Alani,et al.  Peripartum cardiomyopathy: predictors of recovery and current state of implantable cardioverter-defibrillator use. , 2014, Journal of the American College of Cardiology.

[3]  D. Kolte,et al.  Temporal Trends in Incidence and Outcomes of Peripartum Cardiomyopathy in the United States: A Nationwide Population‐Based Study , 2014, Journal of the American Heart Association.

[4]  N. Bello,et al.  The relationship between pre-eclampsia and peripartum cardiomyopathy: a systematic review and meta-analysis. , 2013, Journal of the American College of Cardiology.

[5]  J. Lindenfeld,et al.  Characteristics, adverse events, and racial differences among delivering mothers with peripartum cardiomyopathy. , 2013, JACC. Heart failure.

[6]  S. Goland,et al.  Differences in clinical profile of African-American women with peripartum cardiomyopathy in the United States. , 2013, Journal of cardiac failure.

[7]  C. Berg,et al.  Peripartum Cardiomyopathy: Population-Based Birth Prevalence and 7-Year Mortality , 2012, Obstetrics and gynecology.

[8]  John Mitchell,et al.  Cardiac Angiogenic Imbalance Leads to Peri-partum Cardiomyopathy , 2012, Nature.

[9]  K. Lim,et al.  Angiogenic Factors and the Risk of Adverse Outcomes in Women With Suspected Preeclampsia , 2012, Circulation.

[10]  Cathleen K. Yoshida,et al.  Epidemiology of Peripartum Cardiomyopathy: Incidence, Predictors, and Outcomes , 2011, Obstetrics and gynecology.

[11]  U. Elkayam.  Clinical characteristics of peripartum cardiomyopathy in the United States: diagnosis, prognosis, and management. , 2011, Journal of the American College of Cardiology.

[12]  K. Modi,et al.  Peripartum cardiomyopathy in type II autoimmune polyendocrine syndrome. , 2011, International journal of cardiology.

[13]  K. Sliwa,et al.  Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy , 2010, European journal of heart failure.

[14]  B. Biondi,et al.  Cardiovascular involvement in patients with different causes of hyperthyroidism , 2010, Nature Reviews Endocrinology.

[15]  G. Reed,et al.  African-American women have a higher risk for developing peripartum cardiomyopathy. , 2010, Journal of the American College of Cardiology.

[16]  W. Callaghan,et al.  Cardiomyopathy and Other Myocardial Disorders Among Hospitalizations for Pregnancy in the United States: 2004–2006 , 2010, Obstetrics and gynecology.

[17]  G. Caldito,et al.  Poor outcome of indigent patients with peripartum cardiomyopathy in the United States. , 2009, American journal of obstetrics and gynecology.

[18]  Thomas V. O'brien,et al.  Peripartum cardiomyopathy: prognostic factors for long-term maternal outcome. , 2008, American journal of obstetrics and gynecology.

[19]  M. Özkan,et al.  Predictors of prognosis in patients with peripartum cardiomyopathy , 2008, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[20]  Steven S. Khan,et al.  Incidence, mortality, and racial differences in peripartum cardiomyopathy. , 2007, The American journal of cardiology.

[21]  B. Maisch,et al.  Clinical and immunologic characteristics in peripartum cardiomyopathy. , 2007, International journal of cardiology.

[22]  S. Russell,et al.  Improved outcomes in peripartum cardiomyopathy with contemporary. , 2006, American heart journal.

[23]  M. Gollob,et al.  Frequency of peripartum cardiomyopathy. , 2006, The American journal of cardiology.

[24]  L. Weinert,et al.  Prognostic Value of Echocardiography in Peripartum Cardiomyopathy , 2005, Obstetrics and gynecology.

[25]  M. Sutton,et al.  Racial disparities in reproductive health outcomes. , 2003, American journal of obstetrics and gynecology.

[26]  R. Carraway,et al.  Autoimmune mechanisms as the basis for human peripartum cardiomyopathy , 2002, Clinical reviews in allergy & immunology.

[27]  B. Biondi,et al.  Effects of thyroid hormone on cardiac function: the relative importance of heart rate, loading conditions, and myocardial contractility in the regulation of cardiac performance in human hyperthyroidism. , 2002, The Journal of clinical endocrinology and metabolism.

[28]  R M Lang,et al.  Peripartum heart failure associated with prolonged tocolytic therapy. , 1993, American journal of obstetrics and gynecology.

[29]  J. Hibbard.  CHRONIC TERBUTALINE THERAPY AND PERIPARTUM CARDIOMYOPATHY A CASE-CONTROL STUDY , 1996 .